A proposal for a safe exposure level for diacetylDavid S Egilman
Never Again Consulting, Attleboro, MA, USA
Int J Occup Environ Health 17:122-34. 2011
..The levels of exposure we found to be unsafe include ranges that popcorn consumers may potentially be exposed to, indicating a risk of severe lung disease (including BO) for some consumers...
- Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy
David Egilman
Brown University, Attleboro, MA 02703, USA
Int J Occup Environ Health 13:85-98. 2007
....
- Handling conflicts of interest between industry and academia
David S Egilman
JAMA 289:3240; author reply 3240-1. 2003
- Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies
David Egilman
Clinical Associate Professor, Brown University, Department of Community Health, Providence, Rhode Island, USA
Am J Ind Med 44:540-57. 2003
..Asbestos manufacturing companies and the Canadian government continue to use them to promote the use of asbestos in Europe and in developing countries. Am. J. Ind. Med. 44:540-557, 2003...
What have we learnt from Vioxx?Harlan M Krumholz
Department of Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208088, New Haven, CT 06520 8088, USA
BMJ 334:120-3. 2007
- Bronchiolitis obliterans and consumer exposure to butter-flavored microwave popcorn: a case series
David S Egilman
Department of Family Medicine, Brown University, Providence, Rhode Island, USA
Int J Occup Environ Health 18:29-42. 2012
..Some manufacturers have substituted diacetyl with other alpha-diketones that are likely to pose a similar risk. Simple consumer practices such as cooling the popcorn bag would eliminate the risk of severe lung disease...
- Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology
David Egilman
Brown University, Attleboro, MA 02703, USA
Int J Occup Environ Health 13:118-24. 2007
....
A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec, Canada: A black swan caseDavid Egilman
Brown University, Department of Family Medicine Health, Providence, RI, USA
Am J Ind Med 54:153-6. 2011
..The asbestos industry and scientists it has sponsored, for example, have argued that commercial chrysotile does not cause peritoneal mesothelioma...
- Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony
David Egilman
Department of Community Medicine, Brown University, USA
Int J Occup Environ Health 15:202-28. 2009
..and Price and Ware, and pathologic studies and testimony by Roggli and others, claim that background exposures are benign. These are fatally flawed because of methodological and analytic errors...
- Corporate corruption of science--the case of chromium(VI)
David Egilman
Int J Occup Environ Health 12:169-76. 2006
..This situation demonstrates the insidious and effective influence of industry on the regulatory process...
- Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability
David S Egilman
Department of Community Health, Brown University, Providence, Rhode Island, USA
Int J Occup Environ Health 11:360-71. 2005
..But the absence of evidence is not evidence of the absence of an effect...
- Over a barrel: corporate corruption of science and its effects on workers and the environment
David S Egilman
Int J Occup Environ Health 11:331-7. 2005
..This issue offers examples of how corporations influence science, shows the effects that influence has on environmental and occupational health, and provides evidence of a systemic problem...
- The beryllium "double standard" standard
David S Egilman
Never Again Consulting, Attleboro, MA 02703, USA
Int J Health Serv 33:769-812. 2003
....
- Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation
Susanna Rankin Bohme
Int J Occup Environ Health 11:338-48. 2005
..Public health professionals can learn from this strategy how to effectively build scientific and public opinion that prioritizes both good science and the public health...
- Suppression bias at the Journal of Occupational and Environmental Medicine
David S Egilman
Brown University, Providence, Rhode Island, USA
Int J Occup Environ Health 11:202-4. 2005
..A reputable journal has a responsibility to eschew corporate interests and work to uncover science hidden by interests that do not prioritize the pursuit of truth. JOEM needs to re-examine its priorities...
- Manipulated data in Shell's Benzene Historical Exposure Study
David Egilman
Brown University, Department of Community Health, Providence, Rhode Island, USA
Int J Occup Environ Health 13:222-32. 2007
..A review of the raw data on which Shell and its consultants relied reveals that Shell manipulated and omitted data in order to reach conclusions that exculpated it from liability and helped delay stricter benzene regulation...
- Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial
Samuel D Krumholz
Never Again Consulting LLC, Providence, Rhode Island, USA
Arch Intern Med 171:1100-7. 2011
..Seeding trials, clinical studies conducted by pharmaceutical companies for marketing purposes, have rarely been described in detail...
- American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry
Joseph LaDou
Division of Occupational and Environmental Medicine, University of California School of Medicine, San Francisco, CA 94143 0924, USA
Int J Occup Environ Health 13:404-26. 2007
..This paper chronicles the history of occupational medicine and industry physicians as influenced and even controlled by corporate leaders...
- IJOEH and the critique of bias
David S Egilman
Int J Occup Environ Health 14:147-51. 2008
- Differential peeky bias
David S Egilman
Int J Occup Environ Health 12:294. 2006
- The ADVANTAGE seeding trial: a review of internal documents
Kevin P Hill
McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
Ann Intern Med 149:251-8. 2008
..Seeding trials, clinical studies conducted by pharmaceutical companies that are designed to seem as if they answer a scientific question but primarily fulfill marketing objectives, have not been described in detail...
- Avoiding the regulatory capture of the Food and Drug Administration
David S Egilman
Arch Intern Med 167:732-3. 2007
- Chevron-Texaco's science
David S Egilman
Int J Occup Environ Health 11:456-7. 2005
